197 related articles for article (PubMed ID: 28848560)
1.
Lardone RD; Chan AA; Lee AF; Foshag LJ; Faries MB; Sieling PA; Lee DJ
Front Immunol; 2017; 8():965. PubMed ID: 28848560
[TBL] [Abstract][Full Text] [Related]
2. Insights into Local Tumor Microenvironment Immune Factors Associated with Regression of Cutaneous Melanoma Metastases by
Yang J; Jones MS; Ramos RI; Chan AA; Lee AF; Foshag LJ; Sieling PA; Faries MB; Lee DJ
Front Oncol; 2017; 7():61. PubMed ID: 28424760
[No Abstract] [Full Text] [Related]
3. Immune response to Mycobacterium bovis bacille Calmette Guérin infection in major histocompatibility complex class I- and II-deficient knock-out mice: contribution of CD4 and CD8 T cells to acquired resistance.
Ladel CH; Daugelat S; Kaufmann SH
Eur J Immunol; 1995 Feb; 25(2):377-84. PubMed ID: 7875199
[TBL] [Abstract][Full Text] [Related]
4. Complement C5a anaphylatoxin is an innate determinant of dendritic cell-induced Th1 immunity to Mycobacterium bovis BCG infection in mice.
Moulton RA; Mashruwala MA; Smith AK; Lindsey DR; Wetsel RA; Haviland DL; Hunter RL; Jagannath C
J Leukoc Biol; 2007 Oct; 82(4):956-67. PubMed ID: 17675563
[TBL] [Abstract][Full Text] [Related]
5. Mycobacterium bovis BCG Vaccination Induces Divergent Proinflammatory or Regulatory T Cell Responses in Adults.
Boer MC; Prins C; van Meijgaarden KE; van Dissel JT; Ottenhoff TH; Joosten SA
Clin Vaccine Immunol; 2015 Jul; 22(7):778-88. PubMed ID: 25947145
[TBL] [Abstract][Full Text] [Related]
6. Recombinant Mycobacterium bovis bacillus Calmette-Guérin (BCG) expressing mouse IL-18 augments Th1 immunity and macrophage cytotoxicity.
Luo Y; Yamada H; Chen X; Ryan AA; Evanoff DP; Triccas JA; O'Donnell MA
Clin Exp Immunol; 2004 Jul; 137(1):24-34. PubMed ID: 15196240
[TBL] [Abstract][Full Text] [Related]
7. BCG hydrogel promotes CTSS-mediated antigen processing and presentation, thereby suppressing metastasis and prolonging survival in melanoma.
Kremenovic M; Chan AA; Feng B; Bäriswyl L; Robatel S; Gruber T; Tang L; Lee DJ; Schenk M
J Immunother Cancer; 2022 Jun; 10(6):. PubMed ID: 35732347
[TBL] [Abstract][Full Text] [Related]
8. Ability of T cell subsets and their soluble mediators to modulate the replication of Mycobacterium bovis in bovine macrophages.
Denis M; Wedlock DN; Buddle BM
Cell Immunol; 2004; 232(1-2):1-8. PubMed ID: 15922710
[TBL] [Abstract][Full Text] [Related]
9. Functional characterization of human natural killer cells responding to Mycobacterium bovis bacille Calmette-Guérin.
Esin S; Batoni G; Pardini M; Favilli F; Bottai D; Maisetta G; Florio W; Vanacore R; Wigzell H; Campa M
Immunology; 2004 May; 112(1):143-52. PubMed ID: 15096193
[TBL] [Abstract][Full Text] [Related]
10. Mycobacterium bovis BCG in metastatic melanoma therapy.
Benitez MLR; Bender CB; Oliveira TL; Schachtschneider KM; Collares T; Seixas FK
Appl Microbiol Biotechnol; 2019 Oct; 103(19):7903-7916. PubMed ID: 31402426
[TBL] [Abstract][Full Text] [Related]
11. Mycobacterium bovis bacillus Calmette-Guérin infection induces TLR2-dependent peroxisome proliferator-activated receptor gamma expression and activation: functions in inflammation, lipid metabolism, and pathogenesis.
Almeida PE; Silva AR; Maya-Monteiro CM; Töröcsik D; D'Avila H; Dezsö B; Magalhães KG; Castro-Faria-Neto HC; Nagy L; Bozza PT
J Immunol; 2009 Jul; 183(2):1337-45. PubMed ID: 19561094
[TBL] [Abstract][Full Text] [Related]
12. The predominance of M2-polarized macrophages in the stroma of low-hypoxic bladder tumors is associated with BCG immunotherapy failure.
Lima L; Oliveira D; Tavares A; Amaro T; Cruz R; Oliveira MJ; Ferreira JA; Santos L
Urol Oncol; 2014 May; 32(4):449-57. PubMed ID: 24252833
[TBL] [Abstract][Full Text] [Related]
13. CD4+ T-cell activation by antigen-presenting cells infected with urease-deficient recombinant Mycobacterium bovis bacillus Calmette-Guérin.
Mukai T; Maeda Y; Tamura T; Miyamoto Y; Makino M
FEMS Immunol Med Microbiol; 2008 Jun; 53(1):96-106. PubMed ID: 18400013
[TBL] [Abstract][Full Text] [Related]
14. Selective expansion of perforin-positive CD8+ T cells by immature dendritic cells infected with live Bacillus Calmette-Guérin mycobacteria.
Tsunetsugu-Yokota Y; Tamura H; Tachibana M; Ogata K; Honda M; Takemori T
J Leukoc Biol; 2002 Jul; 72(1):115-24. PubMed ID: 12101270
[TBL] [Abstract][Full Text] [Related]
15. Induction of cross-priming of naive CD8+ T lymphocytes by recombinant bacillus Calmette-Guerin that secretes heat shock protein 70-major membrane protein-II fusion protein.
Mukai T; Maeda Y; Tamura T; Matsuoka M; Tsukamoto Y; Makino M
J Immunol; 2009 Nov; 183(10):6561-8. PubMed ID: 19846882
[TBL] [Abstract][Full Text] [Related]
16. Bacille Calmette-Guérin vaccination enhances human gamma delta T cell responsiveness to mycobacteria suggestive of a memory-like phenotype.
Hoft DF; Brown RM; Roodman ST
J Immunol; 1998 Jul; 161(2):1045-54. PubMed ID: 9670986
[TBL] [Abstract][Full Text] [Related]
17. A novel tumor necrosis factor (TNF) mimetic peptide prevents recrudescence of Mycobacterium bovis bacillus Calmette-Guerin (BCG) infection in CD4+ T cell-depleted mice.
Briscoe H; Roach DR; Meadows N; Rathjen D; Britton WJ
J Leukoc Biol; 2000 Oct; 68(4):538-44. PubMed ID: 11037976
[TBL] [Abstract][Full Text] [Related]
18. Clinical and molecular insights into BCG immunotherapy for melanoma.
Kremenovic M; Schenk M; Lee DJ
J Intern Med; 2020 Dec; 288(6):625-640. PubMed ID: 32128919
[TBL] [Abstract][Full Text] [Related]
19. T-helper 1-like subset selection in Mycobacterium bovis bacillus Calmette-Guérin-infected resistant and susceptible mice.
Kramnik I; Radzioch D; Skamene E
Immunology; 1994 Apr; 81(4):618-25. PubMed ID: 8039813
[TBL] [Abstract][Full Text] [Related]
20. Killed but metabolically active Mycobacterium bovis bacillus Calmette-Guérin retains the antitumor ability of live bacillus Calmette-Guérin.
Secanella-Fandos S; Noguera-Ortega E; Olivares F; Luquin M; Julián E
J Urol; 2014 May; 191(5):1422-8. PubMed ID: 24333111
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
